Dermata Therapeutics, Inc (DRMA) Misses Q2 EPS by 166c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q2 EPS of ($1.66).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Healius Limited (HLS:AU) (PHCRF) to Sector Perform
- B.Riley Starts Precigen Inc. (PGEN) at Buy
- Nomura/Instinet Starts Meesho Ltd (MESSHO:IN) at Reduce
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
